首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Properties of glutamate receptors of Alzheimer's disease brain transplanted to frog oocytes
【24h】

Properties of glutamate receptors of Alzheimer's disease brain transplanted to frog oocytes

机译:移植到青蛙卵母细胞的阿尔茨海默氏病脑中谷氨酸受体的特性

获取原文
获取原文并翻译 | 示例
       

摘要

It is known that Alzheimer's disease (AD) is a synaptic disease that involves various neurotransmitter systems, particularly those where synaptic transmission is mediated by acetylcholine or glutamate (Glu). Nevertheless, very little is known about the properties of neurotransmitter receptors of the AD human brain. We have shown previously that cell membranes, carrying neurotransmitter receptors from the human postmortem brain, can be transplanted to frog oocytes, and their receptors will still be functional. Taking advantage of this fact, we have now studied the properties of Glu receptors (GluRs) from the cerebral cortices of AD and non-AD brains and found that oocytes injected with AD membranes acquired GluRs that have essentially the same functional properties as those of oocytes injected with membranes from non-AD brains. However, the amplitudes of the currents elicited by Glu were always smaller in the oocytes injected with membranes from AD brains. Western blot analyses of the same membrane preparations used for the electrophysiological studies showed that AD membranes contained significantly fewer GluR2/3 subunit proteins. Furthermore, the corresponding mRNAs were also diminished in the AD brain. Therefore, the smaller amplitude of membrane currents elicited by Glu in oocytes injected with membranes from an AD brain is a consequence of a reduced number of GluRs in cell membranes transplanted from the AD brain. Thus, using the comparatively simple method of microtransplantation of receptors, it is now possible to determine the properties of neurotransmitter receptors of normal and diseased human brains. That knowledge may help to decipher the etiology of the diseases and also to develop new treatments.
机译:已知阿尔茨海默氏病(AD)是一种涉及各种神经递质系统的突触疾病,特别是其中乙酰胆碱或谷氨酸(Glu)介导突触传递的系统。然而,关于AD人大脑的神经递质受体的性质知之甚少。以前我们已经表明,携带来自人类死后大脑的神经递质受体的细胞膜可以移植到青蛙卵母细胞中,它们的受体仍将起作用。利用这一事实,我们现在研究了来自AD和非AD大脑皮质的Glu受体(GluRs)的特性,发现注射AD膜的卵母细胞获得的GluR具有与卵母细胞基本相同的功能特性注射非AD大脑的膜。但是,由Glu引起的电流幅度在注入有AD脑膜的卵母细胞中总是较小。对用于电生理研究的相同膜制剂的蛋白质印迹分析表明,AD膜包含的GluR2 / 3亚基蛋白明显减少。此外,AD脑中相应的mRNA也减少了。因此,由AD大脑注射的膜中的卵母细胞中Glu引起的膜电流幅度较小,是从AD大脑移植的细胞膜中的GluR数量减少的结果。因此,使用相对简单的受体微移植方法,现在可以确定正常和患病人脑的神经递质受体的特性。这些知识可能有助于破译疾病的病因并开发新的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号